The Asian Scientist 100
Can Li
Institution
University of Hong Kong
Country
Hong Kong
Field
Engineering
Li is a recipient of the 2023 Croucher Tak Wah Mak Innovation Award for his research exploring the limitations of digital computers in performing tasks accomplished by the human brain, including recognising faces, reasoning based on vague information, and learning from experience.
(Photo: University of Hong Kong)
AWARDS
- 2023 Croucher Tak Wah Mak Innovation Award
Related articles
China Outpaces India For Women In The Workforce
One in six college-educated Indian women works full time for an employer, says Steve Crabtree and Anita Pugliese, based on data from a new Gallup poll.
Soldier Beetles Synthesize Fatty Acids For Defense
Scientists have discovered the three genes that combine to provide soldier beetles with their potent predator defense system.
Quality Education Still A Long Way Off In Pakistan
Despite making education a constitutional right in 2010, Pakistan is unlikely to fulfill its Millennium Development Goal of achieving universal education by 2015.
1000 Genomes Project Helps Advance Personalized Medicine
By decoding the genomes of more than 1,000 people from Han Chinese in Beijing to Japanese in Tokyo, scientists have compiled the largest and most detailed catalog yet of human genetic variation.
Huge Jurassic Fossil Turtle Graveyard Found in China
Paleontologists from Germany have made a spectacular find of 1,800 fossilized turtles from the Jurassic era in China’s northwest province of Xinjiang.
Mainstreaming Science In South Asia
Educating children and women is essential to mainstreaming science in South Asia, writes T. V. Padma.
Koshik The ‘Korean’ Elephant Can Say Annyong, Anja, Aniya, Nuo, And Choah
An Asian elephant named Koshik can imitate human speech, speaking a grand total of five words in Korean by vocalizing with his trunk in his mouth.
TauRx Therapeutics Initiates Two Phase III Trials For Alzheimer’s Drug
Singapore-based biotech company TauRx Therapeutics Ltd announced today the initiation of two global Phase III clinical trials for its Alzheimer’s disease drug.
Del Mar Pharma Announces Strategic Collaboration In China
Del Mar Pharma announced on Monday a strategic collaboration with Guangxi Wuzhou Pharmaceutical Company for the development of VAL-083, known in China as DAG for Injection.









